Wednesday, February 13, 2019
Home »
» Medical News Today: New drug shows promise against several aggressive cancers
Medical News Today: New drug shows promise against several aggressive cancers
Initial trials in humans find that a new drug, tisotumab vedotin, shows significant promise in treating stubborn tumors in several late-stage cancers.
Related Posts:
People gave up on influenza pandemic measures a century ago when they tired of prevention – and many of them paid a price Armistice Day celebrations of the end of World War I on Nov. 11, 1918, worried public-health experts as people crowded together in cities across the United States. (Photo by The Associated Press) By … Read More
Nurses shouldn't have to choose between integrity and compliance, one writes, calling for a standard national work systemThe writer is a licensed practical nurse in Central City. She wrote this for The Leader-News. By Dara Bratcher Integrity is one of the most important qualities a nurse should possess. We must perform our duties completely an… Read More
Kentucky pandemic numbers stay on a rough plateau or decline, contrary to national trend By Bruce Maples Kentucky Health News As the rest of the country is seeing increasing numbers of new Covid-19 cases, Kentucky continues at a rough plateau or even a slight a decline in its numbers, such as its seven-day avera… Read More
Kentucky's one-dose vaccination rate is above adjoining states', but its positive-test and new-case averages have hit plateaus Kentucky Health News graph, based on initial, unadjusted daily reports of cases By Bruce Maples and Al Cross Kentucky Health News As the pandemic in Kentucky showed clear signs of ending its decline and hitting a pl… Read More
Vaccinations coming to Kentucky state prisons next week, after an increasing number of questions about why it took so longBy Bruce Maples and Al CrossKentucky Health News As the state's coronavirus vaccination program has gradually expanded, so have questions about the very limited vaccinations of inmates in the state's prisons. Questions have … Read More
0 comments:
Post a Comment